Table 2.
Pilot study. Measured and calculated parameters with respect to the upper reference limit for serum creatinine (1.02 mg/dL) in women with and without transplants
| Serum creatinine ≤1.02 mg/dL N = 115 | Serum creatinine >1.02 mg/dL N = 40 | |||||
|---|---|---|---|---|---|---|
| Non‐Tx (N = 94) | Tx (N = 21) | P (Mann‐Whitney test) | Non‐Tx (N = 11) | Tx (N = 29) | P (Mann‐Whitney test) | |
| CA125 (kU/L) | 10.7 (8.3‐16.1) | 19.8 (13.6‐26.9) | .000 075 | 21.7 (11.1‐48.8) | 19.1 (12.9‐37.8) | .5855 |
| HE4 (pmol/L) | 50.4 (42.8‐64.5) | 82.8 (63.4‐105.4) | <.000 001 | 345.1 (143.4‐1143.0) | 153.8 (112.3‐263.1) | .0440 |
| Serum creatinine (mg/dL) | 0.79 (0.72‐0.86) | 0.86 (0.79‐0.92) | .017 | 3.08 (1.09‐4.92) | 1.40 (1.21‐1.97) | .2960 |
| ROMA (%) | 7.8 (5.8‐12.6) | 22.1 (13.3‐29.5) | <.000 001 | 85.4 (29.2‐94.8) | 42.7 (30.6‐59.5) | .0814 |
| Age (y) | 47.5 (38.0‐60.0) | 34.0 (29.8‐48.5) | .01 | 47.0 (35.0‐65.8) | 45.0 (37.8‐52.0) | .5443 |
ROMA, Risk of Ovarian Malignancy Algorithm.
Divide by 0.01131 to convert creatinine from mg/dL to μmol/L. Data are given as median (interquartile range).